Thu, Dec 25, 2014, 12:22 AM EST - U.S. Markets closed for Christmas


% | $
Quotes you view appear here for quick access.

Stratasys Ltd. Message Board

hugeman99 5 posts  |  Last Activity: Nov 6, 2014 6:30 PM Member since: Jan 21, 1998
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • RMTI just issued press release and I've been scouring twitter with no answer.

    I thought from the briefing documents that the committee was going to be asked to vote on two questions, the obvious question regarding hemoglobin maintenance, but also as to whether Triferic reduces ESA use.


    I don't have a position but have been watching intently as shorts/longs duked it out.

    Is there somewhere one can listen to recording of the meeting?


  • Reply to


    by johnlas464 Oct 21, 2014 5:06 PM
    hugeman99 hugeman99 Oct 31, 2014 7:36 AM Flag

    Just to put Feuerstein in perspective, he's tweeted a couple of times about how OHRP is failing to publish the data on the second cohort from the Phase II trial, suggesting they are hiding something.

    Would somebody please tell @adamfeuerstein that the second cohort won'f finish treatment until early 2015 as OHRP has stated on multiple occasions. (I'd tell Adam myself but he has blocked me on twitter)

    That is just one blatant example of Adam's rush to judgement. I think Adam resents the fact that OHRP doesn't do any R&D and that they are just exploiting an asset that they picked up on the cheap. I think he's stuggling to accept that maybe there is actually some efficacy even if the company doesn't fully understand the mechanism of action.

    Feuerstein seems to have some kind of chip on his shoulder just like Optimist_77, Feuerstein frequently revels in the misfortune of others. Can you say schadenfreude!.

    As for Optimist_77, as I've said before, I pity the people who have to actually interact with this guy in person.

  • hugeman99 hugeman99 Oct 16, 2014 12:49 PM Flag

    Results of Ebola test expected within 24 hours.

  • Yale Graduate Student who recently traveled to Liberia was admitted to Yale New Haven Hospital today with Ebola Like Symptoms. Hospital currently doing news converences being broadcast on WTNH, channel *. Patient is in isolation.

  • Press release just out.

    Fascinating development. FDA has allowed primary endpoint to be changed to improved visual acuity instead of reduced injections. Makes chances of meeting primary endpoint and FDA approval a heck of a lot better.

    Squalamine certainly won't be the $10B blockbuster L10 was calling for, but now the question is... what would market size be as an adjunct?

    OK Optimist_77, you twisted bitter old man, have at it.

    p.s. Feuerstein couldn't resist a cynical/skeptical tweet predicting doom.

81.12+0.24(+0.30%)Dec 24 1:00 PMEST

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.